Morpheus

From GLP-1 Hub: Support, Community, and Weight Loss

Before You Quit Your GLP-1: What Changed the Second Time w/ Teresa Keever

Published
August 17, 2026
Length
32:46
Starts at
20:50

Audio is streamed from the publisher.

Chapters

Read from the show notes

  1. 0:00 Teresa’s experience with split dosing
  2. 0:28 Why she returned to GLP-1 medication
  3. 1:34 Meet Teresa Keever
  4. 2:17 A lifelong weight-management journey
  5. 3:44 Rethinking willpower and food noise
  6. 5:06 Insurance, telehealth, and compounded tirzepatide
  7. 6:54 Side effects and stopping after eight weeks
  8. 9:05 Returning with a slower, split-dose approach
  9. 10:28 Teresa’s results and current side effects
  10. 11:02 Movement, exercise, nutrition, and protein
  11. 14:09 Family reactions, stigma, and glucose changes
  12. 16:05 Long-term treatment and maintenance
  13. 19:26 Healthcare attitudes, access, and cost
  14. 20:50 Combining telehealth with primary care
  15. 23:04 What to discuss when side effects are difficult
  16. 26:08 Why personalized GLP-1 care matters
  17. 28:53 Visualizing medication levels with GLP-1 Plotter
  18. 30:49 Hopes for the future of GLP-1 treatment
  19. 31:41 Final takeaway and dosing-safety reminder

Not from the publisher — times may be approximate.

Show notes

Send us Fan Mail Teresa Keever’s first experience with tirzepatide lasted only eight weeks. The fatigue and digestive side effects consumed her weekends, left her barely able to eat, and made the standard dosing schedule feel impossible to sustain. Six months later, Teresa tried again, this time working with her provider on a lower, slower, split-dose approach. She shares how that personalized strategy changed her experience, helped make the side effects manageable, and supported a loss of more than 50 pounds. **IN THIS EPISODE** - Why Teresa stopped tirzepatide after only eight weeks - How GLP-1 medication changed her understanding of food noise and willpower - Her experience with compounded medication and split dosing - Why slower titration made treatment more manageable for her - The lifestyle changes that became easier after losing weight - How she approaches protein, exercise, and nutrition without rigid targets - Why she plans to continue GLP-1 treatment for long-term maintenance - The importance of personalized care and ongoing medical oversight **ABOUT THE GUEST** Teresa Keever is a nurse by background who now works in healthcare administration. After years of navigating weight loss and weight management, she began using a GLP-1 medication and ultimately found a clinician-guided approach that better fit her individual needs. She joins the podcast to share her personal experience with side effects, compounded tirzepatide, split dosing, and long-term treatment. **SPONSORS** CaloCurb is a plant-based supplement designed to support appetite control. It is not a replacement for medical care, but it may be one tool to discuss with your healthcare provider. Learn more at https://calocurb.com and use code ANA10 for 10% off. Tyde Wellness offers GLP-1 programs with licensed providers, personalized dosing support, nutrition guidance, and access to a care team. Visit https://tydewellness.com/GLP1Hub and use code GLP1Hub50 for $50 off your first month. **CHAPTERS** 00:00 Teresa’s experience with split dosing 00:28 Why she returned to GLP-1 medication 01:34 Meet Teresa Keever 02:17 A lifelong weight-management journey 03:44 Rethinking willpower and food noise 05:06 Insurance, telehealth, and compounded tirzepatide 06:54 Side effects and stopping after eight weeks 09:05 Returning with a slower, split-dose approach 10:28 Teresa’s results and current side effects 11:02 Movement, exercise, nutrition, and protein 14:09 Family reactions, stigma, and glucose changes 16:05 Long-term treatment and maintenance 19:26 Healthcare attitudes, access, and cost 20:50 Combining telehealth with primary care 23:04 What to discuss when side effects are difficult 26:08 Why personalized GLP-1 care matters 28:53 Visualizing medication levels with GLP-1 Plotter 30:49 Hopes for the future of GLP-1 treatment 31:41 Final takeaway and dosing-safety reminder MORE FROM GLP-1 HUB 📬 Get The Steady State, Ana's weekly newsletter with GLP-1 guidance from a dietitian who's on one: http://join.glp-1hub.com 🎙 Subscribe wherever you listen to podcasts, and if this episode helped, leave a quick review on Apple Podcasts or Spotify - it's the single best way to help more people find the show. 🌐 Shop GLP-1 essentials, meal plans, and recipes: https://shop.glp-1hub.com 📷 Follow on Instagram: @glp1hub 📺 Watch on YouTube: https://www.youtube.com/@GLP-1hub *Some of the links shared are affiliate links. When you make a purchase, I will receive a small commission at no cost to you. Thank you for supporting the show. *The content of this show is for informational purposes only and does not constitute medical advice. The goal of this show is to provide various points of view about GLP-1 Medications. The personal and professional opinion of the guests and their content does not necessarily reflect the opinion of Ana Reisdorf or GLP-1 Hub.